Fred B. Davenport Jr., President at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 69,333 shares at $29.94 ($2.1M) on 2006-11-02, disclosed to the SEC on 2006-11-06.
Open-market sale of $2.1M PPDI by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.69 | 1,300 | $39K | 1.9% |
| 2 | $29.70 | 600 | $18K | 0.9% |
| 3 | $29.71 | 1,400 | $42K | 2.0% |
| 4 | $29.72 | 100 | $3K | 0.1% |
| 5 | $29.73 | 100 | $3K | 0.1% |
| 6 | $29.74 | 100 |
| $3K |
| 0.1% |
| 7 | $29.75 | 1,650 | $49K | 2.4% |
| 8 | $29.76 | 1,350 | $40K | 1.9% |
| 9 | $29.77 | 3,144 | $94K | 4.5% |
| 10 | $29.78 | 9,550 | $284K | 13.7% |
| 11 | $29.79 | 3,400 | $101K | 4.9% |
| 12 | $29.80 | 3,200 | $95K | 4.6% |
| 13 | $29.81 | 1,896 | $57K | 2.7% |
| 14 | $29.82 | 2,925 | $87K | 4.2% |
| 15 | $29.83 | 910 | $27K | 1.3% |
| 16 | $29.84 | 2,500 | $75K | 3.6% |
| 17 | $29.85 | 2,000 | $60K | 2.9% |
| 18 | $29.86 | 1,224 | $37K | 1.8% |
| 19 | $29.87 | 1,853 | $55K | 2.7% |
| 20 | $29.88 | 2,225 | $66K | 3.2% |
| 21 | $29.89 | 3,873 | $116K | 5.6% |
| 22 | $29.90 | 9,847 | $294K | 14.2% |
| 23 | $29.91 | 1,886 | $56K | 2.7% |
| 24 | $29.92 | 1,900 | $57K | 2.7% |
| 25 | $29.93 | 8,600 | $257K | 12.4% |
| 26 | $29.94 | 700 | $21K | 1.0% |
| 27 | $29.95 | 100 | $3K | 0.1% |
| 28 | $29.96 | 400 | $12K | 0.6% |
| 29 | $30.00 | 600 | $18K | 0.9% |
| Total | $29.84 avg | 69,333 | $2.1M | 100% |
| Filing → |
| MEDP | SELL | 2025-04-28 | $1.0M | — | Filing → |
| MEDP | BUY | 2022-02-22 | $73K | — | Filing → |
| PPDI | SELL | 2006-12-19 | $2.2M | — | Filing → |